Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000237094, also known as "Pseudogene similar to part of septin 14" (alias AL732372.2), is classified as a pseudogene, meaning it is a non-functional genomic segment that resembles the protein-coding gene SEPT14 but does not produce a functional protein[3][1]. Pseudogenes generally arise through duplication or retrotransposition events and usually contain defects (e.g., frameshifts, premature stop codons) that prevent them from encoding a protein[4][5]. While some pseudogenes can have regulatory functions at the RNA level—such as acting as competitive endogenous RNAs (ceRNAs) or "microRNA sponges"—there is no evidence or annotation indicating that this specific pseudogene is transcribed, functional, or involved in disease mechanisms[2][3][4][5]. It is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of septin 14.